Sonus Pharmaceuticals Financial Market Data
| Last Close 16-Jul-2008 |
$0.26 |
Price/ Sales Ratio |
0.61 |
| 52-Week High |
$5.32 |
Price/ Book Ratio |
0.33 |
| 52-Week Low |
$0.25 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.6 |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$9.6 |
Return on Assets |
(28.1%) |
| Shares Outstanding (mil.) |
37.1 |
Return on Equity |
(40.8%) |
| Dividend Rate |
-- |
Current Ratio |
6.68 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
33 |
% Owned by Institutions |
18.0% |
| Latest Short Interest Ratio |
1.09 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
(35.5%) |
0.0% |
60,218.5% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
